Navigation Links
Erectile Dysfunction Drug Viagra Launched In India By Pfizer

The most popular drug Viagra has been launched by the pharmaceutical company Pfizer in 30 different cities across India where more than 90 million men are believed to suffer from erectile dysfunction.// The drug company is expected to gain access to approximately 10 to 15 % of the market within the next two years according to K.G. Ananthakrishnan, senior director of drug company in charge of the Indian wing.

Several factors regarding the Indian Pharmaceutical market have been held responsible for Pfizer’s move to market the drug in the country. Although it was not possible to patent a drug in India, from 1970 until the beginning of this year, it was possible to patent the technique of drug production.

This meant that generic forms of the drug could be launched in India while it was against law in several other countries. This led to growth of reverse engineering of the brands that were legally protected elsewhere. Infact, a generic version of Viagra (Sildenafil Citrate) was available in India much before the launch of the launch of the pill in the U.S. drug market before 7 years.

An amendment in the patent law implemented later this year has led to a change in the scenario with the law falling in line with the one prevalent across other parts of the world. This also complies with the World Trade Organization’s TRIPS Agreement according to which a product can be protected against selling of copycat versions by other manufacturers for a period of 20 years.

In moving towards the new set of laws, India agreed that its generics drug companies would pull drugs that are copycat versions of drugs approved elsewhere after 1995. First approved by the FDA in 1998, Viagra brought Pfizer $1.68 billion in revenue in 2004.

A 50-gram dosage of the drug is to be priced at Rs. 463 and a 100 mg tablet at Rs. 594. This higher pricing would limit the affordability of all members of the society. This move only indicates the supreme confidence of Pfizer regarding the removal of other generic versions of Viagra from the Indian market.

This is yet another reason for the anticipated rise in sales of the erectile dysfunction drug. It is hoped that Indian customers would be willing to pay an optimal price for the genuine product.


'"/>




Related medicine news :

1. Erectile dysfunction (ED) signals vascular disease
2. An Exploration into Erectile Dysfunction in Diabetics
3. Erectile dysfunction: an early warning sign of clinically silent coronary artery disease?
4. Cardiovascular Disease More Common Among Erectile Dysfunction Patients
5. Erectile Dysfunction Connected To Heart Disease
6. Statins For Erectile Dysfunction- An Alternative To Viagra?
7. Erectile Dysfunction Can Be Rectified By Healthy Way Of Life
8. Host of Benefits from Erectile Dysfunction Drugs
9. Erectile Dysfunction Linked with Smoking and Obesity – Study Report
10. South Africans Turn to Natural Remedies for Treating Erectile Dysfunction
11. HIV and Erectile Medications - No Link Found
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/27/2017)... ... July 27, 2017 , ... Trusted dentist, speaker and ... sleep apnea in Wayne, NJ to receive custom treatment at his practice ... apnea with the use of custom-crafted oral appliances. Highly-trained in using the latest ...
(Date:7/27/2017)... Viejo, CA (PRWEB) , ... July 27, 2017 , ... ... Cut Pro X . This Final Cut Pro X exclusive features transitions that contain ... and add rotation to the transition using intuitive drop-down menus. TransPanel Volume 4 makes ...
(Date:7/27/2017)... ... 2017 , ... SSCI, a division of Albany Molecular Research, ... representing a milestone achievement. , As an industry-leading provider of ... served as expert and fact witnesses to assist our clients to perform infringement ...
(Date:7/27/2017)... ... July 27, 2017 , ... MAP Health Management, ... year’s Fierce Innovation Awards: Healthcare Edition 2017, an awards program from the publisher ... Population Health Management/Patient Engagement Solutions. , MAP was selected as a finalist ...
(Date:7/27/2017)... ... July 27, 2017 , ... ... 2012-2016, will keynote Day 2 of the HIMSS Healthcare Security Forum, the nation’s ... the Sheraton Boston Hotel, Sept. 11-13, 2017. , Daniel will deliver his keynote, ...
Breaking Medicine News(10 mins):
(Date:7/26/2017)... Sancilio Pharmaceuticals Company, Inc. (SPCI) today announced ... Altemia TM , an oral therapy for pediatric patients ... (SCD). The SCOT Trial, is a double-blind, placebo-controlled, dose-finding, ... Altemia TM in pediatric patients aged 5-17 years ... "The completion of ...
(Date:7/24/2017)... IBM (NYSE: IBM ) has been recognized ... Arrays (SSA) for the fourth year in a row. 1 ... "Vendors in the Leaders quadrant have the highest scores for ... in the Leaders quadrant has the market share, credibility, and ... new technologies. These vendors demonstrate a clear understanding of market ...
(Date:7/21/2017)... 21, 2017  Endo International plc (NASDAQ: ... review of its manufacturing network, the Company will be ... in Huntsville, Alabama . The closure ... the next 12 to 18 months. The ... volumes of commoditized products and these restructuring actions are ...
Breaking Medicine Technology: